Search results
Results from the WOW.Com Content Network
Prolonged QT interval (less common than with most other atypical antipsychotic drugs) [6] Speech disorder; Electrolyte abnormalities including hyponatraemia, hypokalaemia, hypocalcaemia, etc. Hypertension; Dysphagia; Oropharyngeal spasm; Laryngospasm; Hepatitis; Jaundice; Hypersalivation; Chest pain; Urinary retention or incontinence; Alopecia ...
Aripiprazole, sold under the brand names Abilify and Aristada, among others, is an atypical antipsychotic [8] primarily used in the treatment of schizophrenia, bipolar disorder, and irritability associated with autism spectrum disorder; [8] other uses include as an add-on treatment for major depressive disorder and tic disorders. [8]
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), [1] [2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric ...
When two drugs affect each other, it is a drug–drug interaction (DDI). The risk of a DDI increases with the number of drugs used. [1] A large share of elderly people regularly use five or more medications or supplements, with a significant risk of side-effects from drug–drug interactions. [2] Drug interactions can be of three kinds:
If you think a drug makes you sleepy, light-headed, or unfocused, tell your doctor. They may be able to switch you to a different medication or lower the dose. Challenge #4: Health conditions
“Never drive after taking edibles if it’s your first time trying that particular brand and dose,” advises Pearlson. “You don't know how that edible is going to affect you until you’ve ...
Aripiprazole lauroxil, sold under the brand name Aristada, is a long-acting injectable atypical antipsychotic that was developed by Alkermes. [3] [4] [5] It is an N-acyloxymethyl prodrug of aripiprazole that is administered via intramuscular injection once every four to eight weeks for the treatment of schizophrenia.